Upperton Advances Sterile Manufacturing Facility with MHRA Submission

Upperton has formally submitted its application to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for approval of its 7,000 sq. ft sterile manufacturing facility. This submission follows the successful completion of aseptic process simulation (APS) validation batches executed under the stringent requirements of the revised EU GMP Annex 1 (2023) requirements. Nottingham, UK. […]

Upperton Advances Sterile Manufacturing Facility with MHRA Submission Read More »

Upperton Pharma Solutions wins 2025 Integrated Manufacturing Excellence Award

Nottingham, UK. July 7th 2025 – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards. Powered by the global insights platform GlobalData, the Pharmaceutical Technology

Upperton Pharma Solutions wins 2025 Integrated Manufacturing Excellence Award Read More »

Upperton Pharma Solutions completes build of new £7m sterile manufacturing facility

NOTTINGHAM, UK. January 28th, 2025 – Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new facility is in addition to its existing 50,000 sq. ft facility, Trent Gateway, and the purpose-built facility has been designed specifically in line

Upperton Pharma Solutions completes build of new £7m sterile manufacturing facility Read More »